Vulvar Cancer

Why choose us for Vulvar Cancer care?

What you need to know about Vulvar Cancer

Vulvar cancer is a type of cancer that occurs on the outer surface area of the female genitalia, known as the vulva. This area includes the labia majora and minora, the clitoris, the vaginal opening, and the Bartholin’s glands. Vulvar cancer can manifest in various forms, including squamous cell carcinoma (the most common type), adenocarcinoma, melanoma, and sarcoma.

How to talk to your doctor about Vulvar Cancer

  1. Preparation:

    • Organize your thoughts and gather relevant information before the appointment.
    • Write down symptoms, concerns, and questions you want to address.
  2. Honesty and Openness:

    • Be truthful about your symptoms, concerns, and medical history.
    • Provide detailed information about any changes in your vulvar area.
  3. Questions:

    • Ask about tests needed for diagnosis, cancer stage, treatment options, side effects, prognosis, and supportive care.
    • Don’t hesitate to seek clarification on anything you don’t understand.
  4. Note-taking:

    • Take notes during the appointment to remember important details.
    • Consider bringing a trusted companion for support and to help remember information.
  5. Treatment Preferences:

    • Share your treatment preferences, concerns, and fears with your doctor.
    • Collaborate with your doctor to develop a treatment plan aligned with your goals and values.
  6. Follow-up:

    • Understand the next steps in your care, including follow-up appointments, tests, and treatments.
    • Ask about warning signs or symptoms that require immediate medical attention.
  7. Second Opinions:

    • Don’t hesitate to seek a second opinion if you have doubts or concerns about the diagnosis or treatment plan.
    • Ensure you feel confident and informed about your healthcare decisions.

Effective communication with your doctor is crucial for receiving optimal care and support throughout your journey with vulvar cancer.

Vulvar cancer can be classified into several types based on the type of cells from which it originates. The most common type is squamous cell carcinoma, which arises from the skin cells of the vulva. Other types include adenocarcinoma, which originates in the glandular cells, melanoma, which develops from pigment-producing cells called melanocytes, and sarcoma, which originates in the connective tissue cells of the vulva.

  1. Age: It primarily affects older women, with the risk increasing with age.
  2. HPV infection: Certain strains of the human papillomavirus (HPV), particularly HPV types 16 and 18, increase the risk of vulvar cancer.
  3. Smoking: Tobacco use is associated with an increased risk of vulvar cancer.
  4. Immunosuppression: Conditions or medications that weaken the immune system can increase vulnerability to developing vulvar cancer.
  5. Chronic vulvar skin conditions: Conditions such as lichen sclerosus or lichen planus can increase the risk.
  6. History of cervical cancer: Women with a history of cervical cancer have a higher risk.
  7. Vulvar intraepithelial neoplasia (VIN): VIN is a precancerous condition of the vulva, and women with VIN have an increased risk of developing vulvar cancer.
  • Persistent itching, pain, or tenderness in the vulvar area.
  • A lump, ulcer, or wart-like growth on the vulva.
  • Changes in the color or texture of the skin of the vulva.
  • Bleeding that is not related to menstruation.
  • Discomfort or pain during sexual intercourse.

Diagnosis typically involves a pelvic examination, a biopsy of any suspicious lesions, and sometimes imaging tests such as MRI or CT scans to determine the extent of the cancer.

  1. Physical Examination: A pelvic examination allows the healthcare provider to visually inspect the vulva for any abnormalities such as lumps, sores, or changes in the skin’s color or texture.
  2. Biopsy: If suspicious lesions are found during the examination, a biopsy is performed to remove a small sample of tissue for examination under a microscope. This helps to confirm the presence of cancer and determine its type and grade.
  3. Imaging Tests: Imaging tests such as MRI, CT scan, or PET scan may be conducted to assess the extent of the cancer, including whether it has spread to nearby lymph nodes or other organs.
  1. Surgery: Surgery is often the primary treatment for vulvar cancer and may involve various procedures depending on the stage and location of the cancer. Options include:
    • Wide Local Excision: Removal of the cancerous lesion along with a margin of healthy tissue.
    • Partial Vulvectomy: Removal of a portion of the vulva affected by cancer.
    • Radical Vulvectomy: Removal of the entire vulva, including the clitoris and surrounding tissues.
    • Lymph Node Dissection: Removal of nearby lymph nodes to check for the spread of cancer.
  2. Radiation Therapy: Radiation therapy uses high-energy beams to target and destroy cancer cells. It may be used as the primary treatment for early-stage vulvar cancer or in combination with surgery for more advanced cases.
  3. Chemotherapy: Chemotherapy involves the use of drugs to kill cancer cells or stop them from growing. It may be used in combination with surgery and/or radiation therapy, particularly for advanced or recurrent vulvar cancer.
  4. Targeted Therapy: Targeted therapy drugs specifically target certain molecules involved in cancer growth and progression. While not commonly used for vulvar cancer, targeted therapy may be an option in certain cases.

The choice of treatment depends on factors such as the stage and type of cancer, the patient’s overall health and preferences, and the expertise of the healthcare team. Treatment plans are often individualized to optimize outcomes while minimizing side effects and preserving quality of life. Additionally, supportive care such as pain management and counseling may be provided to address the physical and emotional needs of patients undergoing treatment for vulvar cancer. Early detection and prompt treatment offer the best chance for successful outcomes and improved survival rates.